Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

eHealth (EHTH) Cash & Equivalents (2016 - 2025)

eHealth (EHTH) has 17 years of Cash & Equivalents data on record, last reported at $15.6 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 60.3% year-over-year to $15.6 million; the TTM value through Dec 2025 reached $15.6 million, down 60.3%, while the annual FY2025 figure was $15.6 million, 60.3% down from the prior year.
  • Cash & Equivalents reached $15.6 million in Q4 2025 per EHTH's latest filing, down from $63.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $194.7 million in Q2 2022 and bottomed at $15.6 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $110.7 million, with a median of $126.5 million recorded in 2022.
  • The widest YoY moves for Cash & Equivalents: up 1056.95% in 2021, down 88.13% in 2021.
  • A 5-year view of Cash & Equivalents shows it stood at $48.7 million in 2021, then soared by 160.15% to $126.6 million in 2022, then decreased by 8.61% to $115.7 million in 2023, then crashed by 66.13% to $39.2 million in 2024, then tumbled by 60.3% to $15.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $15.6 million in Q4 2025, $63.1 million in Q3 2025, and $59.5 million in Q2 2025.